Australia

Back to map

Showing 11-20 of 30 grants

Title Institution Researcher Program Duration Total Award Amount
Experiences of children with early-stage T1D and their families in three Australian monitoring cohorts: what matters most for engagement in a national program? Adelaide University Jennifer Couper Cures 01-February-2025 to 31-January-2027 $179.817,84
A synergistic approach to preventing islet allograft rejection in beta cell replacement therapy St. Vincent’s Institute of Medical Research Seigmund Lai Cures 01-March-2025 to 29-February-2028 $256.285,00
Engineering an artificial pancreas in the gut for the treatment of diabetes Monash University Rong Xu Improving Lives 01-September-2025 to 31-August-2028 $285.000,00
Improving Glucose Levels while Preventing Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor (PARTNER) The University of Melbourne David O’Neal Improving Lives 01-November-2024 to 31-October-2026 $221.126,00
Investigating the utility of urine C-peptide in early-stage T1D Adelaide University Jennifer Couper Cures 01-September-2024 to 31-July-2026 $93.760,34
Using Multi-omics to turn islet autoimmunity driver genes into therapies Adelaide University Simon Barry Cures 01-August-2024 to 31-July-2027 $446.624,00
Expanded data mining of accumulated functional genomics data for identifying mechanistic biomarkers informative of T1D risk and prevention Adelaide University Megan Penno Cures 01-June-2024 to 31-May-2027 $444.306,96
Finding T1D driver genes: Targets for future therapies Adelaide University Ying Wong Cures 01-March-2024 to 28-February-2027 $267.920,00
A paradigm shift in type 1 diabetes management – building the evidence to optimize care and enable access to disease modifying therapies in the young The University of Western Australia Aveni Haynes Cures 01-March-2024 to 28-February-2029 $999.999,98
Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention. The University of Queensland Josephine Forbes Cures 01-April-2024 to 31-March-2026 $200.000,00